Skip to content
akaturk Academic measurement
Search

Article detail · 2025 · article

Acute myeloid leukemia: a brief historical perspective of AML treatment

Journal Hematology The ISSN points to another catalog journal; the name is from the YÖKSİS record.
ISSN1607-8454
YÖKSİS OpenAlex Open access · gold
Year2025
Citations2OpenAlex
Percentile%84.5
FWCI1.531.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueHematology
  • Catalog match (ISSN)Hematology (United Kingdom)
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Acute Myeloid Leukemia (AML) has been the subject of extensive study by medical professionals and researchers. It is a well-documented type of leukemia, and our understanding of AML has advanced through the efforts of many individuals in the fields of hematology and oncology. There is currently an ongoing and gradual revolution in the research and treatment of acute myeloid leukemia. Recent years have seen significant progress due to advancements in technology, which have played a critical role in untangling the complexities of AML. The history of AML treatment has witnessed remarkable advancements, transitioning from limited options in the early twentieth century to a more refined and targeted approach in the twenty-first century. Continuous research and innovation offer hope for further progress in the field.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2citationsOpenAlex · cited_by_count (cache / database)

Authors

2
  1. SELİN MERİH URLU 1
  2. MUHİT ÖZCAN ANKARA ÜNİVERSİTESİ 2